Related Experiment Videos
Interaction between Candida agglutinins and antifungal agents
Abstract:
Antifungal agents alter the function and morphology of Candida cell membranes and cell walls. We observed that brief (30 minute) exposure to either amphotericin B or clotrimazole inhibited the agglutination of Candida blastoconidia by murine bronchoalveolar lavage fluid. This inhibition required continuous drug presence. Neither amphotericin nor clotrimazole inhibited Candida agglutination by concanavalin A or pooled human serum. These results demonstrate that antifungal drugs can produce rapid changes in the surface characteristics of some fungi.
Insights
Antifungal drugs like amphotericin B and clotrimazole rapidly change Candida fungi surfaces. These drugs inhibit fungal agglutination by specific fluids, but only when continuously present.
Area of Science:
- Mycology
- Pharmacology
- Immunology
Background:
- Antifungal agents are crucial for treating Candida infections.
- Understanding how these drugs affect fungal cell surfaces is important for treatment efficacy.
Purpose of the Study:
- To investigate the rapid effects of antifungal drugs on Candida blastoconidia surface characteristics.
- To determine if amphotericin B and clotrimazole alter fungal agglutination properties.
Main Methods:
- Exposure of Candida blastoconidia to amphotericin B or clotrimazole for 30 minutes.
- Assessing fungal agglutination using murine bronchoalveolar lavage fluid, concanavalin A, and human serum.
Main Results:
- Both amphotericin B and clotrimazole inhibited Candida agglutination by murine bronchoalveolar lavage fluid.
- This inhibitory effect was dependent on the continuous presence of the antifungal drugs.
- Neither drug affected Candida agglutination mediated by concanavalin A or human serum.
Conclusions:
- Antifungal drugs can induce rapid alterations in the surface properties of Candida.
- These changes are specific to the interaction with certain biological fluids, like murine bronchoalveolar lavage fluid.